Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer.
de Carpeño JC, Barón MG, Aguiar J, Chacón JI, Feliu J, García MJ, Madroñal C, Colmenarejo A, Sánchez JJ, Ordóñez A; Oncopaz Cooperative Group (Spain). de Carpeño JC, et al. Among authors: colmenarejo a. Cancer Chemother Pharmacol. 2006 Aug;58(2):266-71. doi: 10.1007/s00280-005-0143-z. Epub 2005 Nov 25. Cancer Chemother Pharmacol. 2006. PMID: 16308698
Treatment of advanced gastric cancer with the combination fluorouracil, leucovorin, etoposide, and cisplatin: a phase II study of the ONCOPAZ Cooperative Group.
González-Barón M, Feliu J, Espinosa E, García-Girón C, Chacón I, Garrido P, Colmenarejo A, Ordóñez A, Zamora P. González-Barón M, et al. Among authors: colmenarejo a. Cancer Chemother Pharmacol. 1995;36(3):255-8. doi: 10.1007/BF00685856. Cancer Chemother Pharmacol. 1995. PMID: 7781148 Clinical Trial.
Comparison of two chemotherapeutic regimens--mitomycin + vindesine + cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP)--in advanced non-small-cell lung cancer. ONCOPAZ Cooperative Group.
González Barón M, Feliu J, Espinosa E, García Girón C, Blanco E, Garrido P, Colmenarejo A, Ordóñez A, Moyano A, de la Gándara I, et al. González Barón M, et al. Among authors: colmenarejo a. Ann Oncol. 1994 Apr;5(4):323-7. doi: 10.1093/oxfordjournals.annonc.a058834. Ann Oncol. 1994. PMID: 8075028 Free article. Clinical Trial.
Treatment of metastatic malignant melanoma with cisplatin plus tamoxifen.
Feliu J, González Barón M, Chacón JI, Espinosa E, Garrido P, Castro J, Escobar Y, Colmenarejo A, Jara C, García Girón C, Espinosa J, Ordóñez A. Feliu J, et al. Among authors: colmenarejo a. Cancer Chemother Pharmacol. 1996;38(2):191-4. doi: 10.1007/s002800050469. Cancer Chemother Pharmacol. 1996. PMID: 8616911 Clinical Trial.
UFT modulated with leucovorin in advanced colorectal cancer: Oncopaz experience.
González Barón M, Feliu J, Garcia Girón C, Espinosa J, Martinez B, Blanco E, Crespo MC, Ordóñez A, Espinosa E, de Castro J, Juárez F, Colmenarejo A. González Barón M, et al. Among authors: colmenarejo a. Oncology. 1997;54 Suppl 1:24-9. doi: 10.1159/000227742. Oncology. 1997. PMID: 8978581 Clinical Trial.
Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group.
Feliu J, González Barón M, Espinosa E, García Girón C, de la Gándara I, Espinosa J, Colmenarejo A, Jalón JI, Fernández Y, de Castro J. Feliu J, et al. Among authors: colmenarejo a. Cancer. 1997 May 15;79(10):1884-9. doi: 10.1002/(sici)1097-0142(19970515)79:10<1884::aid-cncr7>3.0.co;2-g. Cancer. 1997. PMID: 9149013
Activity and safety of oxaliplatin with weekly 5-fluorouracil bolus and low-dose leucovorin as first-line treatment for advanced colorectal cancer.
Cassinello J, Escudero P, Salud A, Marcos F, Pujol E, Pérez-Carrión R, Colmenarejo A, González del Val R, Valero J, Oruezábal MJ, Guillem V, García I, Arcediano A, Marfà X. Cassinello J, et al. Among authors: colmenarejo a. Clin Colorectal Cancer. 2003 Aug;3(2):108-12. doi: 10.3816/CCC.2003.n.017. Clin Colorectal Cancer. 2003. PMID: 12952567 Clinical Trial.
15 results